ACP-105

Description

60 capsules 10mg

ACP-105: Quality muscle tissue through unrivalled selective binding

Developed in the laboratories of Acadia Pharmaceuticals in Sweden,according to study results ACP 105 has shown potent anabolic effects on muscle and bone with little side effects.

Studies show ACP-105 attaches itself to the androgen receptor even better than DHTor dihydrotestosterone, an androgen produced as a byproduct of testosterone and known for its great, highly selective receptor binding capabilities. These unique capabilities make ACP-105 one of the most promising SARMs in our portfolio.

• Highly anabolic with positive safety profile
• Very selective receptor binding capabilities
• Suitable for cutting, recomposition, bulking

For laboratory and research purposes only.